Last 12 months
Inside the activity.
0 purchase rows · 38 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 11 |
| Feb 2026 | 0 | 7 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 4 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 13 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 22, 2025 Filed May 23, 2025 20:40 UTC |
Gilman MichaelDirector
|
GrantCommon Stock | 7,632 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-052471 · tm2516084-2_4seq1.xml · nonDerivative · entry 1 Gilman Michael · CIK 0001291144 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,591 F1 · shares: Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to this RSU vest on the earlier of June 15, 2026 or on the date of the Issuer's next Annual Meeting subject to continued service to the Issuer through such date. F2 · balance_after: Consists of 50,959 shares of Common Stock and 7,632 RSUs. Read SEC document |
| May 22, 2025 Filed May 23, 2025 20:39 UTC |
FLIER JEFFREY S.Director
|
GrantStock Option (Right to Buy) · Derivative | 9,206 | $0.00 Strike: $30.46 | $0.00 |
DisclosureSEC source: 0001104659-25-052470 · tm2516084-1_4seq1.xml · derivative · entry 3 FLIER JEFFREY S. · CIK 0001740266 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,206 Underlying: Common Stock · 9,206 shares Expires 2035-05-22 F4 · derivative.exercise_date: Options to vest and become fully exercisable on the earlier of the first anniversary following the date of grant or on the date of the Issuer's next Annual Meeting subject to continued service to the Issuer through such date. Read SEC document |
| May 22, 2025 Filed May 23, 2025 20:39 UTC |
FLIER JEFFREY S.Director
|
GrantCommon Stock | 7,632 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-052470 · tm2516084-1_4seq1.xml · nonDerivative · entry 1 FLIER JEFFREY S. · CIK 0001740266 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,145 F1 · shares: Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to this RSU vest on the earlier of June 15, 2026 or on the date of the Issuer's next Annual Meeting subject to continued service to the Issuer through such date. F2 · balance_after: Consists of 22,513 shares of Common Stock and 7,632 RSUs. Read SEC document |
| May 02, 2025 Filed May 6, 2025 21:02 UTC |
Woods KeithChief Operating Officer
|
GrantStock Option (Right to Buy) · Derivative | 110,067 | $0.00 Strike: $32.91 | $0.00 |
DisclosureSEC source: 0001104659-25-045117 · tm2513936-4_4seq1.xml · derivative · entry 1 Woods Keith · CIK 0001996804 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 110,067 Underlying: Common Stock · 110,067 shares Expires 2035-05-02 F1 · derivative.exercise_date: 25% of the shares underlying this option shall vest on April 27, 2026, with the remainder vesting in twelve equal quarterly installments thereafter; provided the reporting person continues to have a service relationship with the Issuer on each such vesting date. Read SEC document |
| May 02, 2025 Filed May 6, 2025 21:01 UTC |
Vaishnaw AkshayDirector · President of R&D
|
GrantStock Option (Right to Buy) · Derivative | 110,067 | $0.00 Strike: $32.91 | $0.00 |
DisclosureSEC source: 0001104659-25-045116 · tm2513936-3_4seq1.xml · derivative · entry 1 Vaishnaw Akshay · CIK 0001458494 · Director · President of R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 110,067 Underlying: Common Stock · 110,067 shares Expires 2035-05-02 F1 · derivative.exercise_date: 25% of the shares underlying this option shall vest on April 27, 2026, with the remainder vesting in twelve equal quarterly installments thereafter; provided the reporting person continues to have a service relationship with the Issuer on each such vesting date. Read SEC document |
| May 02, 2025 Filed May 6, 2025 21:01 UTC |
Sinha VikasChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 110,067 | $0.00 Strike: $32.91 | $0.00 |
DisclosureSEC source: 0001104659-25-045114 · tm2513936-2_4seq1.xml · derivative · entry 1 Sinha Vikas · CIK 0001337845 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 110,067 Underlying: Common Stock · 110,067 shares Expires 2035-05-02 F1 · derivative.exercise_date: 25% of the shares underlying this option shall vest on April 27, 2026, with the remainder vesting in twelve equal quarterly installments thereafter; provided the reporting person continues to have a service relationship with the Issuer on each such vesting date. Read SEC document |
| May 02, 2025 Filed May 6, 2025 21:00 UTC |
Hallal DavidDirector · Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 275,167 | $0.00 Strike: $32.91 | $0.00 |
DisclosureSEC source: 0001104659-25-045112 · tm2513936-1_4seq1.xml · derivative · entry 1 Hallal David · CIK 0001457477 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 275,167 Underlying: Common Stock · 275,167 shares Expires 2035-05-02 F1 · derivative.exercise_date: 25% of the shares underlying this option shall vest on April 27, 2026, with the remainder vesting in twelve equal quarterly installments thereafter; provided the reporting person continues to have a service relationship with the Issuer on each such vesting date. Read SEC document |
| April 27, 2025 Filed Apr 29, 2025 22:08 UTC |
Vaishnaw AkshayDirector · President of R&D
|
GrantCommon Stock | 500,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-041460 · tm2513505-6_4seq1.xml · nonDerivative · entry 2 Vaishnaw Akshay · CIK 0001458494 · Director · President of R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 622,955 F2 · shares: Represents performance based RSUs subject to performance- and time-based vesting conditions (the "PSUs"). The amount reported herein represents the maximum number of shares of the Issuer's common stock that may be issued under this award. The shares subject to this PSU vest in tranches of a combination of performance vesting tied to the Issuer's common stock achieving certain price targets and time-based vesting over four years, provided the reporting person continues to have a service relationship with the Issuer on each such vesting date. Any PSUs that have not vested on or prior to April 27, 2029 will be forfeited for no consideration. Read SEC document |
| April 27, 2025 Filed Apr 29, 2025 22:08 UTC |
Vaishnaw AkshayDirector · President of R&D
|
GrantCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-041460 · tm2513505-6_4seq1.xml · nonDerivative · entry 1 Vaishnaw Akshay · CIK 0001458494 · Director · President of R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 122,955 F1 · shares: Represents restricted stock units ("RSUs") subject to time-based vesting conditions. Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to this RSU vest in four annual installments over four years, with the first annual installment to vest on April 15, 2026 and each additional installment to vest annually thereafter; provided the reporting person continues to have a service relationship with the Issuer on each such vesting date. Read SEC document |
| April 27, 2025 Filed Apr 29, 2025 22:10 UTC |
Woods KeithChief Operating Officer
|
GrantCommon Stock | 500,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-041464 · tm2513505-7_4seq1.xml · nonDerivative · entry 2 Woods Keith · CIK 0001996804 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 600,000 F2 · shares: Represents performance based RSUs subject to performance- and time-based vesting conditions (the "PSUs"). The amount reported herein represents the maximum number of shares of the Issuer's common stock that may be issued under this award. The shares subject to this PSU vest in tranches of a combination of performance vesting tied to the Issuer's common stock achieving certain price targets and time-based vesting over four years, provided the reporting person continues to have a service relationship with the Issuer on each such vesting date. Any PSUs that have not vested on or prior to April 27, 2029 will be forfeited for no consideration. Read SEC document |
| April 27, 2025 Filed Apr 29, 2025 22:10 UTC |
Woods KeithChief Operating Officer
|
GrantCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-041464 · tm2513505-7_4seq1.xml · nonDerivative · entry 1 Woods Keith · CIK 0001996804 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 F1 · shares: Represents restricted stock units ("RSUs") subject to time-based vesting conditions. Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to this RSU vest in four annual installments over four years, with the first annual installment to vest on April 15, 2026 and each additional installment to vest annually thereafter; provided the reporting person continues to have a service relationship with the Issuer on each such vesting date. Read SEC document |
| April 27, 2025 Filed Apr 29, 2025 22:07 UTC |
Hallal DavidDirector · CEO
|
GrantCommon Stock | 1,250,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-041457 · tm2513505-5_4seq1.xml · nonDerivative · entry 2 Hallal David · CIK 0001457477 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,804,095 F2 · shares: Represents performance based RSUs subject to performance- and time-based vesting conditions (the "PSUs"). The amount reported herein represents the maximum number of shares of the Issuer's common stock that may be issued under this award. The shares subject to this PSU vest in tranches of a combination of performance vesting tied to the Issuer's common stock achieving certain price targets and time-based vesting over four years, provided the reporting person continues to have a service relationship with the Issuer on each such vesting date. Any PSUs that have not vested on or prior to April 27, 2029 will be forfeited for no consideration. Read SEC document |
| April 27, 2025 Filed Apr 29, 2025 22:07 UTC |
Hallal DavidDirector · CEO
|
GrantCommon Stock | 250,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-041457 · tm2513505-5_4seq1.xml · nonDerivative · entry 1 Hallal David · CIK 0001457477 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 554,095 F1 · shares: Represents restricted stock units ("RSUs") subject to time-based vesting conditions. Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to this RSU vest in four annual installments over four years, with the first annual installment to vest on April 15, 2026 and each additional installment to vest annually thereafter; provided the reporting person continues to have a service relationship with the Issuer on each such vesting date. Read SEC document |
| April 27, 2025 Filed Apr 29, 2025 22:05 UTC |
Sinha VikasChief Financial Officer
|
GrantCommon Stock | 500,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-041454 · tm2513505-4_4seq1.xml · nonDerivative · entry 2 Sinha Vikas · CIK 0001337845 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 600,000 F2 · shares: Represents performance based RSUs subject to performance- and time-based vesting conditions (the "PSUs"). The amount reported herein represents the maximum number of shares of the Issuer's common stock that may be issued under this award. The shares subject to this PSU vest in tranches of a combination of performance vesting tied to the Issuer's common stock achieving certain price targets and time-based vesting over four years, provided the reporting person continues to have a service relationship with the Issuer on each such vesting date. Any PSUs that have not vested on or prior to April 27, 2029 will be forfeited for no consideration. Read SEC document |
| April 27, 2025 Filed Apr 29, 2025 22:05 UTC |
Sinha VikasChief Financial Officer
|
GrantCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-041454 · tm2513505-4_4seq1.xml · nonDerivative · entry 1 Sinha Vikas · CIK 0001337845 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 F1 · shares: Represents restricted stock units ("RSUs") subject to time-based vesting conditions. Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to this RSU vest in four annual installments over four years, with the first annual installment to vest on April 15, 2026 and each additional installment to vest annually thereafter; provided the reporting person continues to have a service relationship with the Issuer on each such vesting date. Read SEC document |
| April 25, 2025 Filed Apr 29, 2025 22:03 UTC |
Sacco TraceyChief Commercial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $10.00 | $0.00 |
DisclosureSEC source: 0001104659-25-041451 · tm2513505-1_4seq1.xml · derivative · entry 4 Sacco Tracey · CIK 0001980334 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 185,000 Underlying: Common Stock · 5,000 shares Expires 2033-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on December 20, 2024. F7 · derivative.exercise_date: 112,500 shares remain unvested under this stock option. The first vesting event occurred on February 6, 2024 and the remainder vests in twelve quarterly installments thereafter; provided the reporting person continues to have a service relationship with the Issuer on such vesting date. Read SEC document |
| April 25, 2025 Filed Apr 29, 2025 22:03 UTC |
Sacco TraceyChief Commercial Officer
|
SaleCommon Stock | 84 | $33.49 | $2,812.74 |
DisclosureSEC source: 0001104659-25-041451 · tm2513505-1_4seq1.xml · nonDerivative · entry 3 Sacco Tracey · CIK 0001980334 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 71,750 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on December 20, 2024. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $33.37 to $33.53, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F6 · balance_after: Consists of 6,931 shares of common stock and 64,819 RSUs. Read SEC document |
| April 25, 2025 Filed Apr 29, 2025 22:03 UTC |
Sacco TraceyChief Commercial Officer
|
SaleCommon Stock | 4,916 | $32.81 | $161,318.05 |
DisclosureSEC source: 0001104659-25-041451 · tm2513505-1_4seq1.xml · nonDerivative · entry 2 Sacco Tracey · CIK 0001980334 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 71,834 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on December 20, 2024. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $32.46 to $33.36, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F4 · balance_after: Consists of 7,015 shares of common stock and 64,819 RSUs. Read SEC document |
| April 25, 2025 Filed Apr 29, 2025 22:03 UTC |
Sacco TraceyChief Commercial Officer
|
Exercise / conversionCommon Stock | 5,000 | $10.00 | $50,000.00 |
DisclosureSEC source: 0001104659-25-041451 · tm2513505-1_4seq1.xml · nonDerivative · entry 1 Sacco Tracey · CIK 0001980334 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 76,250 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on December 20, 2024. F2 · balance_after: Consists of 11,931 shares of common stock and 64,819 RSUs. Read SEC document |
| March 24, 2025 Filed Mar 25, 2025 23:39 UTC |
Sacco TraceyChief Commercial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $10.00 | $0.00 |
DisclosureSEC source: 0001415889-25-008976 · form4-03252025_110328.xml · derivative · entry 4 Sacco Tracey · CIK 0001980334 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 190,000 Underlying: Common Stock · 5,000 shares Expires 2033-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on December 20, 2024. F7 · derivative.exercise_date: 112,500 shares remain unvested under this stock option. The first vesting event occurred on February 6, 2024 and the remainder vests in twelve quarterly installments thereafter; provided the reporting person continues to have a service relationship with the Issuer on such vesting date. Read SEC document |
| March 24, 2025 Filed Mar 25, 2025 23:39 UTC |
Sacco TraceyChief Commercial Officer
|
SaleCommon Stock | 5,000 | $32.89 | $164,458.50 |
DisclosureSEC source: 0001415889-25-008976 · form4-03252025_110328.xml · nonDerivative · entry 3 Sacco Tracey · CIK 0001980334 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 71,750 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on December 20, 2024. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $32.52 to $33.44, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F6 · balance_after: Consists of 6,931 shares of common stock and 64,819 RSUs. Read SEC document |
| March 24, 2025 Filed Mar 25, 2025 23:39 UTC |
Sacco TraceyChief Commercial Officer
|
SaleCommon Stock | 1,500 | $33.70 | $50,555.55 |
DisclosureSEC source: 0001415889-25-008976 · form4-03252025_110328.xml · nonDerivative · entry 2 Sacco Tracey · CIK 0001980334 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 76,750 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on December 20, 2024. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $33.52 to $34.02, inclusive. Full information regarding the number of shares sold at each. F4 · balance_after: Consists of 11,931 shares of common stock and 64,819 RSUs. Read SEC document |
| March 24, 2025 Filed Mar 25, 2025 23:39 UTC |
Sacco TraceyChief Commercial Officer
|
Exercise / conversionCommon Stock | 5,000 | $10.00 | $50,000.00 |
DisclosureSEC source: 0001415889-25-008976 · form4-03252025_110328.xml · nonDerivative · entry 1 Sacco Tracey · CIK 0001980334 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 78,250 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on December 20, 2024. F2 · balance_after: Consists of 13,431 shares of common stock and 64,819 RSUs. Read SEC document |
| March 24, 2025 Filed Mar 25, 2025 23:37 UTC |
Moore ErinInterim PFO and PAO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 8,564 | $0.00 Strike: $13.52 | $0.00 |
DisclosureSEC source: 0001415889-25-008972 · form4-03252025_110359.xml · derivative · entry 5 Moore Erin · CIK 0001790859 · Interim PFO and PAO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 40,724 Underlying: Common Stock · 8,564 shares Expires 2030-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on December 18, 2024. F6 · derivative.exercise_date: No shares remain unvested under this stock option. Read SEC document |
| March 24, 2025 Filed Mar 25, 2025 23:37 UTC |
Moore ErinInterim PFO and PAO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $23.86 | $0.00 |
DisclosureSEC source: 0001415889-25-008972 · form4-03252025_110359.xml · derivative · entry 4 Moore Erin · CIK 0001790859 · Interim PFO and PAO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,764 Underlying: Common Stock · 5,000 shares Expires 2028-10-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on December 18, 2024. F6 · derivative.exercise_date: No shares remain unvested under this stock option. Read SEC document |
| March 24, 2025 Filed Mar 25, 2025 23:37 UTC |
Moore ErinInterim PFO and PAO
|
SaleCommon Stock | 13,564 | $33.12 | $449,236.97 |
DisclosureSEC source: 0001415889-25-008972 · form4-03252025_110359.xml · nonDerivative · entry 3 Moore Erin · CIK 0001790859 · Interim PFO and PAO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 82,609 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on December 18, 2024. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $33.00 to $33.55, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F5 · balance_after: Consists of 15,380 shares of common stock and 67,229 RSUs. Read SEC document |
| March 24, 2025 Filed Mar 25, 2025 23:37 UTC |
Moore ErinInterim PFO and PAO
|
Exercise / conversionCommon Stock | 8,564 | $13.52 | $115,785.28 |
DisclosureSEC source: 0001415889-25-008972 · form4-03252025_110359.xml · nonDerivative · entry 2 Moore Erin · CIK 0001790859 · Interim PFO and PAO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 96,173 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on December 18, 2024. F3 · balance_after: Consists of 28,944 shares of common stock and 67,229 RSUs. Read SEC document |
| March 24, 2025 Filed Mar 25, 2025 23:37 UTC |
Moore ErinInterim PFO and PAO
|
Exercise / conversionCommon Stock | 5,000 | $23.86 | $119,300.00 |
DisclosureSEC source: 0001415889-25-008972 · form4-03252025_110359.xml · nonDerivative · entry 1 Moore Erin · CIK 0001790859 · Interim PFO and PAO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 87,609 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on December 18, 2024. F2 · balance_after: Consists of 20,380 shares of common stock and 67,229 RSUs. Read SEC document |
| March 17, 2025 Filed Mar 19, 2025 21:00 UTC |
Peng KatieDirector
|
SaleCommon Stock | 1,006 | $34.42 | $34,626.92 |
DisclosureSEC source: 0001415889-25-008593 · form4-03192025_050301.xml · nonDerivative · entry 1 Peng Katie · CIK 0001983850 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 30,319 F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on November 20, 2024 to cover tax obligations upon the vesting and settlement of restricted stock units. F2 · balance_after: Consists of 8,680 shares of common stock and 21,639 RSUs. Read SEC document |
| March 10, 2025 Filed Mar 12, 2025 17:00 UTC | GrantStock Option (Right to Buy) · Derivative | 31,430 | $0.00 Strike: $35.15 | $0.00 |
DisclosureSEC source: 0001415889-25-007841 · form4-03122025_050316.xml · derivative · entry 2 Parlavecchio Caryn · CIK 0001922346 · CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,430 Underlying: Common Stock · 31,430 shares Expires 2035-03-10 F3 · derivative.exercise_date: Options to vest in sixteen quarterly installments over four years, with the first quarterly installment to vest on April 1, 2025 and each additional installment to vest quarterly thereafter; provided the individual continues to have a service relationship with the Issuer on such vesting date. Read SEC document |
|
| March 10, 2025 Filed Mar 12, 2025 17:00 UTC | GrantCommon Stock | 23,570 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-007841 · form4-03122025_050316.xml · nonDerivative · entry 1 Parlavecchio Caryn · CIK 0001922346 · CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 163,828 F1 · shares: Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to this RSU vest in four annual installments over four years, with the first annual installment to vest on February 15, 2026 and each additional installment to vest annually thereafter; provided the reporting person continues to have a service relationship with the Issuer on such vesting date. F2 · balance_after: Consists of 58,469 shares of common stock and 105,359 RSUs Read SEC document |
|
| March 10, 2025 Filed Mar 12, 2025 21:00 UTC |
Backstrom Jay T.Director · CHIEF EXECUTIVE OFFICER
|
GrantStock Option (Right to Buy) · Derivative | 151,430 | $0.00 Strike: $35.15 | $0.00 |
DisclosureSEC source: 0001415889-25-007839 · form4-03122025_050311.xml · derivative · entry 2 Backstrom Jay T. · CIK 0001796398 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 151,430 Underlying: Common Stock · 151,430 shares Expires 2035-03-10 F3 · derivative.exercise_date: Options to vest in sixteen quarterly installments over four years, with the first quarterly installment to vest on April 1, 2025 and each additional installment to vest quarterly thereafter; provided the individual continues to have a service relationship with the Issuer on such vesting date. Read SEC document |
| March 10, 2025 Filed Mar 12, 2025 21:00 UTC |
Backstrom Jay T.Director · CHIEF EXECUTIVE OFFICER
|
GrantCommon Stock | 113,570 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-007839 · form4-03122025_050311.xml · nonDerivative · entry 1 Backstrom Jay T. · CIK 0001796398 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 425,561 F1 · shares: Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to this RSU vest in four annual installments over four years, with the first annual installment to vest on February 15, 2026 and each additional installment to vest annually thereafter; provided the reporting person continues to have a service relationship with the Issuer on such vesting date. F2 · balance_after: Consists of 76,277 shares of common stock and 349,284 RSUs Read SEC document |
| March 10, 2025 Filed Mar 12, 2025 23:06 UTC |
Myles Edward HCOO & CFO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 17,857 | $0.00 Strike: $15.75 | $0.00 |
DisclosureSEC source: 0001104659-25-023059 · tm259035-1_4seq1.xml · derivative · entry 12 Myles Edward H · CIK 0001358219 · COO & CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 53,573 Underlying: Common Stock · 17,857 shares Expires 2034-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on November 19, 2024. F15 · derivative.exercise_date: Options to vest in sixteen quarterly installments over four years, with the first quarterly installment to vest on April 1, 2024 and each additional installment to vest quarterly thereafter; provided the individual continues to have a service relationship with the Issuer on such vesting date. Read SEC document |
| March 10, 2025 Filed Mar 12, 2025 23:06 UTC |
Myles Edward HCOO & CFO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,313 | $0.00 Strike: $10.00 | $0.00 |
DisclosureSEC source: 0001104659-25-023059 · tm259035-1_4seq1.xml · derivative · entry 11 Myles Edward H · CIK 0001358219 · COO & CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 42,500 Underlying: Common Stock · 5,313 shares Expires 2033-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on November 19, 2024. F14 · derivative.exercise_date: The shares underlying this option vest in sixteen quarterly installments over four years, with the first quarterly installment vested on April 1, 2023 and each additional installment to vest quarterly thereafter; provided the individual continues to have a service relationship with the Issuer on each such vesting date. Read SEC document |
| March 10, 2025 Filed Mar 12, 2025 23:06 UTC |
Myles Edward HCOO & CFO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 24,915 | $0.00 Strike: $4.86 | $0.00 |
DisclosureSEC source: 0001104659-25-023059 · tm259035-1_4seq1.xml · derivative · entry 10 Myles Edward H · CIK 0001358219 · COO & CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 12,462 Underlying: Common Stock · 24,915 shares Expires 2032-06-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on November 19, 2024. F13 · derivative.exercise_date: Options vest and become exercisable in twelve quarterly installments over three years, with the first quarterly installment to vest on September 16, 2022 and each additional installment to vest quarterly thereafter, provided the individual continues to have a service relationship with the Company on such vesting date. Read SEC document |
| March 10, 2025 Filed Mar 12, 2025 23:06 UTC |
Myles Edward HCOO & CFO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 43,122 | $0.00 Strike: $18.08 | $0.00 |
DisclosureSEC source: 0001104659-25-023059 · tm259035-1_4seq1.xml · derivative · entry 9 Myles Edward H · CIK 0001358219 · COO & CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 14,378 Underlying: Common Stock · 43,122 shares Expires 2032-02-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on November 19, 2024. F12 · derivative.exercise_date: Options vest and become exercisable in sixteen quarterly installments over four years. Vesting commenced on January 1, 2022 and the first vesting event shall occur three months thereafter; provided the reporting person continues to have a service relationship with the Company on such vesting date. Read SEC document |
| March 10, 2025 Filed Mar 12, 2025 23:06 UTC |
Myles Edward HCOO & CFO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 21,690 | $0.00 Strike: $13.83 | $0.00 |
DisclosureSEC source: 0001104659-25-023059 · tm259035-1_4seq1.xml · derivative · entry 8 Myles Edward H · CIK 0001358219 · COO & CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 21,690 shares Expires 2030-07-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on November 19, 2024. F11 · derivative.exercise_date: 100% of the shares underlying the option are fully vested. Read SEC document |
| March 10, 2025 Filed Mar 12, 2025 23:06 UTC |
Myles Edward HCOO & CFO
|
SaleCommon Stock | 29,395 | $34.87 | $1,025,003.65 |
DisclosureSEC source: 0001104659-25-023059 · tm259035-1_4seq1.xml · nonDerivative · entry 7 Myles Edward H · CIK 0001358219 · COO & CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 111,345 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on November 19, 2024. F9 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $34.53 to $35.025, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F10 · balance_after: Consists of 111,345 RSUs. Read SEC document |
| March 10, 2025 Filed Mar 12, 2025 23:06 UTC |
Myles Edward HCOO & CFO
|
SaleCommon Stock | 112,897 | $35.82 | $4,043,970.54 |
DisclosureSEC source: 0001104659-25-023059 · tm259035-1_4seq1.xml · nonDerivative · entry 6 Myles Edward H · CIK 0001358219 · COO & CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 140,740 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on November 19, 2024. F7 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $35.03 to $35.765, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F8 · balance_after: Consists of 29,395 shares of common stock and 111,345 RSUs. Read SEC document |
| March 10, 2025 Filed Mar 12, 2025 23:06 UTC |
Myles Edward HCOO & CFO
|
Exercise / conversionCommon Stock | 17,857 | $15.75 | $281,247.75 |
DisclosureSEC source: 0001104659-25-023059 · tm259035-1_4seq1.xml · nonDerivative · entry 5 Myles Edward H · CIK 0001358219 · COO & CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 253,637 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on November 19, 2024. F6 · balance_after: Consists of 142,292 shares of common stock and 111,345 RSUs. Read SEC document |
| March 10, 2025 Filed Mar 12, 2025 23:06 UTC |
Myles Edward HCOO & CFO
|
Exercise / conversionCommon Stock | 5,313 | $10.00 | $53,130.00 |
DisclosureSEC source: 0001104659-25-023059 · tm259035-1_4seq1.xml · nonDerivative · entry 4 Myles Edward H · CIK 0001358219 · COO & CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 235,780 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on November 19, 2024. F5 · balance_after: Consists of 124,435 shares of common stock and 111,345 RSUs. Read SEC document |
| March 10, 2025 Filed Mar 12, 2025 23:06 UTC |
Myles Edward HCOO & CFO
|
Exercise / conversionCommon Stock | 24,915 | $4.86 | $121,086.90 |
DisclosureSEC source: 0001104659-25-023059 · tm259035-1_4seq1.xml · nonDerivative · entry 3 Myles Edward H · CIK 0001358219 · COO & CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 230,467 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on November 19, 2024. F4 · balance_after: Consists of 119,122 shares of common stock and 111,345 RSUs. Read SEC document |
| March 10, 2025 Filed Mar 12, 2025 23:06 UTC |
Myles Edward HCOO & CFO
|
Exercise / conversionCommon Stock | 43,122 | $18.08 | $779,645.76 |
DisclosureSEC source: 0001104659-25-023059 · tm259035-1_4seq1.xml · nonDerivative · entry 2 Myles Edward H · CIK 0001358219 · COO & CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 205,552 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on November 19, 2024. F3 · balance_after: Consists of 94,207 shares of common stock and 111,345 RSUs. Read SEC document |
| March 10, 2025 Filed Mar 12, 2025 23:06 UTC |
Myles Edward HCOO & CFO
|
Exercise / conversionCommon Stock | 21,690 | $13.83 | $299,972.70 |
DisclosureSEC source: 0001104659-25-023059 · tm259035-1_4seq1.xml · nonDerivative · entry 1 Myles Edward H · CIK 0001358219 · COO & CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 162,430 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on November 19, 2024. F2 · balance_after: Consists of 51,085 shares of common stock and 111,345 restricted stock units ("RSUs"). Read SEC document |
| March 10, 2025 Filed Mar 12, 2025 21:00 UTC |
Qatanani MoCHIEF SCIENTIFIC OFFICER
|
GrantStock Option (Right to Buy) · Derivative | 42,855 | $0.00 Strike: $35.15 | $0.00 |
DisclosureSEC source: 0001415889-25-007842 · form4-03122025_050318.xml · derivative · entry 2 Qatanani Mo · CIK 0001980298 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,855 Underlying: Common Stock · 42,855 shares Expires 2035-03-10 F3 · derivative.exercise_date: Options to vest in sixteen quarterly installments over four years, with the first quarterly installment to vest on April 1, 2025 and each additional installment to vest quarterly thereafter; provided the individual continues to have a service relationship with the Issuer on such vesting date. Read SEC document |
| March 10, 2025 Filed Mar 12, 2025 21:00 UTC |
Qatanani MoCHIEF SCIENTIFIC OFFICER
|
GrantCommon Stock | 32,145 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-007842 · form4-03122025_050318.xml · nonDerivative · entry 1 Qatanani Mo · CIK 0001980298 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 143,229 F1 · shares: Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to this RSU vest in four annual installments over four years, with the first annual installment to vest on February 15, 2026 and each additional installment to vest annually thereafter; provided the reporting person continues to have a service relationship with the Issuer on such vesting date. F2 · balance_after: Consists of 20,259 shares of common stock and 122,970 RSUs Read SEC document |
| March 10, 2025 Filed Mar 12, 2025 21:00 UTC |
Marantz Jing L.CHIEF MEDICAL OFFICER
|
GrantStock Option (Right to Buy) · Derivative | 45,715 | $0.00 Strike: $35.15 | $0.00 |
DisclosureSEC source: 0001415889-25-007840 · form4-03122025_050314.xml · derivative · entry 2 Marantz Jing L. · CIK 0001834528 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,715 Underlying: Common Stock · 45,715 shares Expires 2035-03-10 F3 · derivative.exercise_date: Options to vest in sixteen quarterly installments over four years, with the first quarterly installment to vest on April 1, 2025 and each additional installment to vest quarterly thereafter; provided the individual continues to have a service relationship with the Issuer on such vesting date. Read SEC document |
| March 10, 2025 Filed Mar 12, 2025 21:00 UTC |
Marantz Jing L.CHIEF MEDICAL OFFICER
|
GrantCommon Stock | 34,285 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-007840 · form4-03122025_050314.xml · nonDerivative · entry 1 Marantz Jing L. · CIK 0001834528 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,485 F1 · shares: Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to this RSU vest in four annual installments over four years, with the first annual installment to vest on February 15, 2026 and each additional installment to vest annually thereafter; provided the reporting person continues to have a service relationship with the Issuer on such vesting date. F2 · balance_after: Consists of 12,558 shares of common stock and 88,927 RSUs Read SEC document |
| March 10, 2025 Filed Mar 12, 2025 21:00 UTC |
Sacco TraceyChief Commercial Officer
|
GrantStock Option (Right to Buy) · Derivative | 37,145 | $0.00 Strike: $35.15 | $0.00 |
DisclosureSEC source: 0001415889-25-007837 · form4-03122025_050307.xml · derivative · entry 2 Sacco Tracey · CIK 0001980334 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,145 Underlying: Common Stock · 37,145 shares Expires 2035-03-10 F3 · derivative.exercise_date: Options to vest in sixteen quarterly installments over four years, with the first quarterly installment to vest on April 1, 2025 and each additional installment to vest quarterly thereafter; provided the individual continues to have a service relationship with the Issuer on such vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.